• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者预防椎体骨折的治疗目标

Treatment Goals for Prevention of Vertebral Fractures in Patients with Rheumatoid Arthritis.

作者信息

Mochizuki Takeshi, Ando Mari, Yano Koichiro, Hiroshima Ryo, Ikari Katsunori, Okazaki Ken

机构信息

Department of Orthopaedic Surgery, Kamagaya General Hospital, Chiba, Japan.

Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

J Bone Metab. 2025 Feb;32(1):49-56. doi: 10.11005/jbm.24.811. Epub 2025 Feb 28.

DOI:10.11005/jbm.24.811
PMID:40098429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11960298/
Abstract

BACKGROUND

Patients with rheumatoid arthritis (RA) are at an increased risk of osteoporosis and vertebral fractures. This study aimed to investigate factors associated with vertebral fractures and treatment goals to prevent new vertebral fractures in patients with RA.

METHODS

The database used in this study included outpatient data of RA patients at the authors' hospital of RA patients taken from 2018 to 2022. The patients underwent annual imaging evaluations to assess parameters, including bone mineral density of the lumbar spine (LS; L2-4), total hip, and femoral neck, as well as vertebral fractures. Vertebral fractures were evaluated using radiographic images of the T8 to L5 vertebrae.

RESULTS

The prevalence rates of new vertebral fractures in 2018-2019, 2019-2020, 2020- 2021, and 2021-2022 were 2.0%, 1.3%, 2.3%, and 2.0%, respectively. The presence of existing vertebral fractures was associated with new vertebral fractures (p=0.003; odds ratio, 0.241; 95% confidence interval, 0.093-0.624). The cut-off T-score values for the LS for new vertebral fractures in patients with or without pre-existing vertebral fractures were -0.7 (sensitivity, 40.9%; specificity, 100%) and -1.4 (sensitivity, 69.0%; specificity, 62.5%), respectively.

CONCLUSIONS

The presence of pre-existing vertebral fractures is an independent factor associated with new vertebral fractures. It is important to tailor treatment goals based on the presence or absence of vertebral fractures to effectively prevent new fractures.

摘要

背景

类风湿关节炎(RA)患者发生骨质疏松和椎体骨折的风险增加。本研究旨在调查与椎体骨折相关的因素以及预防RA患者新发椎体骨折的治疗目标。

方法

本研究使用的数据库包括作者所在医院2018年至2022年RA患者的门诊数据。患者每年接受影像学评估以评估参数,包括腰椎(LS;L2 - 4)、全髋和股骨颈的骨密度以及椎体骨折情况。使用T8至L5椎体的X线影像评估椎体骨折。

结果

2018 - 2019年、2019 - 2020年、2020 - 2021年和2021 - 2022年新发椎体骨折的患病率分别为2.0%、1.3%、2.3%和2.0%。既往椎体骨折的存在与新发椎体骨折相关(p = 0.003;比值比,0.241;95%置信区间,0.093 - 0.624)。有或无既往椎体骨折患者新发椎体骨折时腰椎的截断T值分别为 - 0.7(敏感性,40.9%;特异性,100%)和 - 1.4(敏感性,69.0%;特异性,62.5%)。

结论

既往椎体骨折的存在是与新发椎体骨折相关的独立因素。根据是否存在椎体骨折调整治疗目标对于有效预防新发骨折很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/658615010938/jbm-24-811f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/8e5e96ebb34f/jbm-24-811f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/1020f066166d/jbm-24-811f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/658615010938/jbm-24-811f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/8e5e96ebb34f/jbm-24-811f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/1020f066166d/jbm-24-811f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2631/11960298/658615010938/jbm-24-811f3.jpg

相似文献

1
Treatment Goals for Prevention of Vertebral Fractures in Patients with Rheumatoid Arthritis.类风湿关节炎患者预防椎体骨折的治疗目标
J Bone Metab. 2025 Feb;32(1):49-56. doi: 10.11005/jbm.24.811. Epub 2025 Feb 28.
2
Association between vertebral fractures and comorbidities in patients with rheumatoid arthritis: a cross-sectional study.类风湿关节炎患者椎体骨折与合并症之间的关联:一项横断面研究。
J Bone Miner Metab. 2025 Mar 27. doi: 10.1007/s00774-025-01597-9.
3
Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients.在类风湿关节炎患者中,采用胸腹部骨盆 CT 扫描进行椎体密度的机会性筛查。
Osteoporos Int. 2019 Jun;30(6):1215-1222. doi: 10.1007/s00198-019-04931-w. Epub 2019 Mar 13.
4
High frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis-Results from TOMORROW study.类风湿关节炎患者椎体骨折发生率高且骨质量低——TOMORROW 研究结果。
Mod Rheumatol. 2017 May;27(3):398-404. doi: 10.1080/14397595.2016.1213943. Epub 2016 Aug 2.
5
Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.尽管近年来治疗取得了进展,但类风湿关节炎患者的椎体骨折发生率仍增加:一项病例对照研究。
Osteoporos Int. 2021 Jul;32(7):1333-1342. doi: 10.1007/s00198-021-05824-7. Epub 2021 Jan 18.
6
Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score.利用骨密度和小梁骨评分识别患有脊椎骨折的类风湿关节炎患者。
J Clin Densitom. 2012 Jul-Sep;15(3):260-6. doi: 10.1016/j.jocd.2012.01.007. Epub 2012 Mar 21.
7
[Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases : Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures].[炎症性风湿性疾病和非炎症性疾病患者常规临床护理中骨小梁评分(TBS)的评估:与传统骨密度测量的相关性及椎体骨折患病率]
Z Rheumatol. 2020 Dec;79(10):1067-1074. doi: 10.1007/s00393-020-00764-9.
8
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.一项关于类风湿关节炎骨密度的多中心横断面研究。意大利类风湿关节炎骨量研究组。
J Rheumatol. 2000 Nov;27(11):2582-9.
9
Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.骨小梁评分(TBS)和四肢肌肉质量低导致的骨微结构损伤:长期患有类风湿关节炎的女性发生椎体和非椎体骨折的主要危险因素。
Osteoporos Int. 2024 May;35(5):819-830. doi: 10.1007/s00198-024-07026-3. Epub 2024 Jan 25.
10
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.odanacatib 治疗绝经后骨质疏松症:LOFT 多中心、随机、双盲、安慰剂对照试验和 LOFT 扩展研究的结果。
Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31.

本文引用的文献

1
Challenges in the management of older patients with inflammatory rheumatic diseases.老年炎症性风湿病患者管理面临的挑战。
Nat Rev Rheumatol. 2022 Jun;18(6):326-334. doi: 10.1038/s41584-022-00768-6. Epub 2022 Mar 21.
2
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.类风湿关节炎患者的骨质疏松症:2007 - 2017年德国国家数据库中的趋势
Rheumatol Int. 2020 Dec;40(12):2005-2012. doi: 10.1007/s00296-020-04593-6. Epub 2020 May 6.
3
A large observational cohort study of rheumatoid arthritis, IORRA: Providing context for today's treatment options.
一项关于类风湿性关节炎的大型观察性队列研究,IORRA:为当今的治疗选择提供背景信息。
Mod Rheumatol. 2020 Jan;30(1):1-6. doi: 10.1080/14397595.2019.1660028. Epub 2019 Oct 1.
4
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis.类风湿关节炎的骨质疏松病理生理学、流行病学和筛查。
Curr Rheumatol Rep. 2019 May 23;21(7):34. doi: 10.1007/s11926-019-0836-7.
5
Osteoblast autophagy in glucocorticoid-induced osteoporosis.成骨细胞自噬在糖皮质激素诱导性骨质疏松症中的作用。
J Cell Physiol. 2019 Apr;234(4):3207-3215. doi: 10.1002/jcp.27335. Epub 2018 Nov 11.
6
The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials.糖皮质激素对类风湿关节炎患者骨密度的影响:一项随机对照试验的系统评价和荟萃分析。
Bone. 2018 Sep;114:172-180. doi: 10.1016/j.bone.2018.06.008. Epub 2018 Jun 18.
7
The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study.日本类风湿关节炎的发病年龄呈上升趋势:一项全国性数据库研究。
Int J Rheum Dis. 2017 Jul;20(7):839-845. doi: 10.1111/1756-185X.12998. Epub 2017 Feb 16.
8
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.骨质疏松症的目标导向治疗:美国骨矿研究学会 - 美国国家骨质疏松基金会骨质疏松症目标导向治疗工作组的进展报告
J Bone Miner Res. 2017 Jan;32(1):3-10. doi: 10.1002/jbmr.3039. Epub 2016 Dec 27.
9
Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).唑来膦酸每年一次给药对日本原发性骨质疏松症患者的疗效和安全性:一项随机安慰剂对照双盲研究的两年结果(唑来膦酸治疗骨质疏松症的疗效;ZONE研究)
Osteoporos Int. 2017 Jan;28(1):389-398. doi: 10.1007/s00198-016-3736-y. Epub 2016 Sep 8.
10
Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study.类风湿关节炎患者骨折的发生率及危险因素:一项亚洲前瞻性队列研究。
Rheumatol Int. 2016 Sep;36(9):1205-14. doi: 10.1007/s00296-016-3453-z. Epub 2016 Mar 10.